跳至主要内容
临床试验/NCT01775878
NCT01775878已完成不适用

A Randomized Study Comparing Usual Diabetes Care Management to Telemetric Home-based Monitoring of Glucose and Blood Pressure in Patients With Diabetes (TELEGAP)

Kaiser Permanente0 个研究点目标入组 254 人开始时间: 2009年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
254
主要终点
Fructosamine

研究概览

简要总结

The study is a two-arm, parallel-comparison, single-blind, randomized controlled trial, and will be offered to Kaiser Permanente members aged 18 - 75 years old who present to the Santa Rosa Diabetes Care Management Center with Type 2 diabetes mellitus. Participants will be randomly assigned to one of two treatment arms. The telemedicine group or the group receiving usual care (the control group).

This study hopes to show the usefulness of this telemonitoring technology and more specifically, to assess whether this device improves markers of control of diabetes, glycemic control, and cardiovascular risk factors

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 - 75 years old,
  • •diagnosis of type 2 diabetes mellitus for at least 1 month,
  • •eligible for and referred to the diabetes care management program,
  • •HbA1c values in the range: 7.5% to 10.5%.

排除标准

  • •Weight > 330 lbs,
  • •estimated glomerular filtration rate (GFR) < 45,
  • •unstable coronary artery disease,
  • •severe peripheral vascular disease which restricted exercise,
  • •end-stage liver disease,
  • •undergoing treatment for cancer,
  • •pregnant or not using appropriate birth control,
  • •no broadband internet access in their homes.

研究组 & 干预措施

Usual Care

No Intervention

This arm received usual care from the diabetes care managers

Telemonitoring Device

Experimental

Patients in this arm received a telemonitoring device installed in their homes

干预措施: Telemonitoring Device (Device)

结局指标

主要结局

Fructosamine

时间窗: 6 weeks

Change from baseline to 6 weeks in serum fructosamine levels

glycosylated hemoglobin

时间窗: 6 months

change from baseline to 6 months in serum HbA1c levels

次要结局

  • blood pressure(6 weeks and 6 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验